Sequoia invests Rs 100 cr in La Renon Healthcare
Company will use proceeds to strengthen its R&D capabilities
)
Ahmedabad-based La Renon Healthcare, a pharmaceutical research, marketing and manufacturing company, has raised Rs. 100 crore in first institutional funding (Series A) from Sequoia Capital.
The company will use the investment to strengthen its R&D capabilities and to expand into new categories within the chronic diseases management space, it said in a press statement.
Founded by Pankaj Singh, La Renon provides pharmaceutical products and services for various critical illnesses and diseases.
“Chronic diseases are fast becoming a major health risk for a majority of Indians, largely due to factors relating to the changing modern lifestyle. At La Renon, it is our aim to develop and market new and innovative solutions to address these chronic health issues," said Pankaj Singh, Founder, Chairman and CEO of La Reno.
The company will use the investment to strengthen its R&D capabilities and to expand into new categories within the chronic diseases management space, it said in a press statement.
Founded by Pankaj Singh, La Renon provides pharmaceutical products and services for various critical illnesses and diseases.
“Chronic diseases are fast becoming a major health risk for a majority of Indians, largely due to factors relating to the changing modern lifestyle. At La Renon, it is our aim to develop and market new and innovative solutions to address these chronic health issues," said Pankaj Singh, Founder, Chairman and CEO of La Reno.
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jun 12 2015 | 8:46 PM IST